Table 2.
Baseline prevalence rate of CVD in different stages of CKD in C-STRIDE Study (Nov 2011–Mar 2016)
| Variable | eGFR (ml/min/1.73 m2) | P for trend | ||||
|---|---|---|---|---|---|---|
| Total | >60 | 45–60 | 30–45 | 15–30 | ||
| (n = 3168) | (n = 975) | (n = 497) | (n = 769) | (n = 927) | ||
| MI | 64 (20.58) | 6 (0.62) | 9 (1.81) | 22 (2.86) | 27 (2.91) | 0.001 |
| CHF | 28 (9.00) | 3 (0.31) | 5 (1.01) | 9 (1.17) | 11 (1.19) | 0.14 |
| Cerebrovascular disease | 215 (69.13) | 22 (2.26) | 44 (8.85) | 58 (7.54) | 91 (9.82) | <0.001 |
| PAD | 50 (10.08) | 3 (0.31) | 8 (1.61) | 13 (1.69) | 26 (2.81) | <0.001 |
| Total CVD | 311 (9.82) | 31 (3.18) | 59 (11.87) | 86 (11.18) | 135 (14.56) | |
Categorical data are presented as numbers (n) of patients and percentages. MI myocardial infarction, CHF congestive heart failure, PAD peripheral arterial disease